[1]CurrentPatentAssignee:APTOSEBIOSCIENCESINC.-US2010/168417,2010,A1Locationinpatent:Page/Pagecolumn31
[1]Tsai,Cheng-Yu;Sun,Si;Zhang,Hongying;Local,Andrea;Su,Yongxuan;Gross,LarryA.;Rice,WilliamG.;Howell,StephenB.[MolecularCancerTherapeutics,2018,vol.17,#6,p.1167-1176]
Title: Local A, et al. APTO-253 Stabilizes G-quadruplex DNA, Inhibits MYC Expression, and Induces DNA Damage in Acute Myeloid Leukemia Cells. Mol Cancer Ther. 2018 Jun;17(6):1177-1186.
Title: Hongying Zhang, et al. Inhibition of c-Myc By Apto-253 As an Innovative Therapeutic Approach to Induce Cell Cycle Arrest and Apoptosis in Acute Myeloid Leukemia. Blood 2016 128:1716.
Title: Haruka Tsuchiya, et al. Parsing multiomics landscape of activated synovial fibroblasts highlights drug targets linked to genetic risk of rheumatoid arthritis. Ann Rheum Dis. 2020 Nov2;annrheumdis-2020-218189.
